CC-NEFRO Film-coated tablets, 200 pcs

Instructions for use for CC-NEFRO Film-coated tablets, 200 pcs

Information for use of the article CC Nefro Film-Coated Tablets: CC-Nefro 500 mg Film-Coated Tablets contain the active substance calcium carbonate and are used for the treatment of increased serum phosphate (hyperphosphataemia) in chronic renal failure, especially in patients undergoing dialysis treatment. The dosage depends on the serum phosphate level in the blood. The recommended dose for adults is usually 1-3 tablets three times daily. The maximum dosage of 7 tablets per day should not be exceeded. The film-coated tablets should be taken unchewed with some liquid immediately before or with meals. There are insufficient data on the use in children and adolescents under 18 years of age, therefore the use in this patient group is not recommended. It is important to monitor therapy with CC-Nefro regularly by a doctor. In the event of an overdose, symptoms such as muscle weakness, abdominal pain, constipation, nausea, vomiting, thirst, cardiac arrhythmia and unconsciousness may occur. Before using the medicinal product, possible contraindications should be taken into account, such as an allergy to calcium carbonate, excessive calcium concentrations in the blood, lowered serum phosphate, calcium-containing kidney stones and the absence of free hydrochloric acid in the gastric juice. There are also warnings and precautions, for example in case of impaired kidney function, increased calcium excretion in the urine, lowered phosphate concentration in the blood and additional intake of calcium or alkalis. Pregnant and breastfeeding women should consult their doctor before use. Taking CC-Nefro may lead to increased calcium excretion in the urine, increasing the risk of formation of kidney and bladder stones. To avoid this, it is recommended to drink enough fluids. No information is available on the effects on the ability to drive and operate machinery. The package leaflet should be read carefully before use. Ask your doctor or pharmacist if you have any further questions on the use of this medicine. The information is taken from the package leaflet of the manufacturer MEDICE Arzneimittel Pütter GmbH in Iserlohn. Source: Information in the package leaflet, as of 07/2021